Bridgewater Associates’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$479K Sell
992
-749,948
-100% -$199M ﹤0.01% 928
2026
Q1
$82.3M Buy
750,940
+510,410
+212% +$72.7M 0.37% 51
2025
Q4
$40M Buy
240,530
+223,052
+1,276% +$37.3M 0.15% 114
2025
Q3
$3.42M Sell
17,478
-62,759
-78% -$10.3M 0.01% 582
2025
Q2
$7.26M Buy
+80,237
New +$6.34M 0.03% 294

Other funds holding ALAB

Bridgewater Associates's ALAB Position: Q2 2026 in Review

Bridgewater Associates reduced its Astera Labs (ALAB) stake by 100% in Q2 2026, selling an estimated $199M and leaving 992 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #928.

Bridgewater Associates first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. The position peaked at $82.3M in Q1 2026. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Bridgewater Associates held 992 shares of Astera Labs worth $479K as of Q2 2026.
  • Bridgewater Associates sold 749,948 Astera Labs shares in Q2 2026, an estimated $199M.
  • Astera Labs made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #928 holding.
  • Bridgewater Associates first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • Bridgewater Associates's Astera Labs position peaked at $82.3M in Q1 2026.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.